Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed)

This grant supports the development and adaptation of technologies for identifying, characterizing, and understanding senescent cell heterogeneity within tissue environments and secretomes. It funds a two-phase, five-year project: an initial UG3 phase to create and demonstrate feasibility, followed by a UH3 phase to optimize, validate, and apply the technology in collaborative validation studies.